Cannabis is the clinical umbrella term for every product derived from the Cannabis sativa plant, not just the dried flower most people picture when they hear the word marijuana. It includes flower, hashish, concentrates such as dabs, wax, and shatter, vape oils, and edibles, each of which delivers tetrahydrocannabinol, or THC, the plant’s primary psychoactive compound, at a different speed and intensity. THC acts on the body’s endocannabinoid system, binding to receptors concentrated in the prefrontal cortex, hippocampus, and amygdala, the very regions that govern decision making, memory, and emotional regulation. Clinicians favor the broader term cannabis precisely because it captures this full range of preparations and potencies, rather than the single image of a joint that shaped public perception for decades. Understanding cannabis this way matters, because the products on shelves and in vape cartridges today bear little chemical resemblance to what circulated a generation ago. That shift has real consequences for how the brain responds, how quickly dependence can develop, and how treatment needs to be structured.
For a growing number of people, cannabis use crosses a threshold from casual or occasional use into Cannabis Use Disorder, a pattern of use recognized in the DSM-5 as a legitimate, diagnosable medical condition. This shift often surprises families who grew up believing cannabis was mild or non habit forming, yet the clinical evidence is clear that tolerance, dependence, and withdrawal are all possible outcomes of sustained heavy use. At Carrara Treatment, we see cannabis use disorder less as a character flaw and more as a signal, frequently an adaptive response to unresolved trauma, chronic anxiety, or unmanaged stress that cannabis temporarily quiets. Naming the condition accurately is the first step toward treating it effectively, because a diagnosable disorder calls for a structured clinical response rather than willpower alone. The good news is that cannabis use disorder responds well to the right combination of medical support, psychotherapy, and dual diagnosis care. With accurate assessment and compassionate, evidence-based treatment, full recovery is genuinely within reach.
What Is Cannabis Use Disorder, and How Do Clinicians Diagnose It?
Cannabis Use Disorder is defined in the DSM-5 through a set of eleven specific criteria that fall into four broad domains: impaired control over use, social or occupational impairment, risky use, and pharmacological indicators such as tolerance and withdrawal. Impaired control might look like using more cannabis than intended, repeated unsuccessful attempts to cut back, or spending significant time obtaining, using, or recovering from its effects. Social and occupational impairment includes continuing to use despite relationship conflict, or letting cannabis interfere with work, school, or family responsibilities. Risky use covers situations like driving under the influence, while tolerance means needing progressively more cannabis to reach the same effect. A clinician diagnoses the disorder when a person meets at least two of these eleven criteria within a twelve-month period, and severity is graded by the total number met: two or three criteria indicate a mild disorder, four or five indicate moderate, and six or more indicate a severe disorder.
In practice, cannabis use disorder rarely shows up in isolation. Many people who meet criteria for the condition are also living with anxiety, depression, PTSD, or another co-occurring mental health condition, and cannabis is frequently the tool someone reached for first to manage symptoms that were never properly treated. A thorough clinical assessment looks at the full picture, including patterns of use, mental health history, physical health, and life circumstances, rather than focusing on cannabis alone. This is why Carrara Treatment’s dual diagnosis approach matters so much: treating the use disorder without addressing the anxiety, trauma, or mood condition underneath it rarely produces lasting change. Every assessment is conducted with person-first, non-judgmental language, because how a diagnosis is delivered shapes whether someone feels safe enough to engage in treatment at all.
What Happens During Cannabis Withdrawal, and How Is Cannabis Addiction Treated?
Cannabis withdrawal syndrome is a formally recognized clinical condition that can emerge within a day or two after a person with heavy, long-term cannabis use stops or significantly cuts back. Common symptoms include irritability, anxiety, restlessness, and sleep disturbances marked by vivid or unsettling dreams. Appetite often decreases in the early days, and many people report physical discomfort such as headaches, sweating, chills, or stomach upset. These symptoms typically peak within the first week after stopping and gradually improve over the following one to two weeks, although disrupted sleep can persist longer for some people. Because withdrawal can feel genuinely destabilizing, especially for someone already managing anxiety or a mood condition, medical supervision during this period can make the process considerably safer and more comfortable.
There is currently no FDA-approved medication specifically for cannabis use disorder, so effective treatment relies on evidence-based behavioral therapies rather than a single prescription. Cognitive behavioral therapy helps identify the thoughts and triggers that drive use, motivational interviewing builds internal motivation for change, and contingency management reinforces progress along the way. At Carrara Treatment, care begins with medically supervised support through withdrawal and continues with dual diagnosis treatment, EMDR, somatic trauma therapy, and other trauma-focused modalities delivered in a private residential setting. This integrated approach treats cannabis use disorder as the medical condition it is, addressing both the dependence and whatever pain it may have been covering, and the center reports a 92 percent success rate among clients who complete the program.
Frequently Asked Questions
Can a person really become addicted to cannabis?
Yes. Research confirms that regular cannabis use can lead to Cannabis Use Disorder, a diagnosable condition marked by loss of control, strong cravings, and continued use despite clear negative consequences. An estimated three in ten people who use cannabis develop some degree of the disorder, and risk climbs with earlier first use, more frequent use, and higher-potency products. It is a medical condition, not a personal failing, and it responds well to proper treatment.
Why is today’s cannabis so much more potent than it used to be?
Decades ago, cannabis flower averaged a low single-digit percentage of THC. Today’s flower commonly tests between fifteen and twenty-five percent, and concentrates like wax, shatter, and vape oils can exceed seventy or even ninety percent THC. This dramatic rise delivers a far more intense dose to the brain’s reward circuitry, raising the risk of dependence, acute anxiety, and, in vulnerable individuals, cannabis-associated psychosis.
How long does cannabis withdrawal typically last?
Withdrawal symptoms, including irritability, anxiety, sleep disruption, vivid dreams, and appetite loss, usually begin within one to three days of stopping heavy, long-term use. They tend to peak during the first week and gradually ease over the following one to two weeks, though disrupted sleep can linger longer for some people. Medically supervised care can make this process significantly safer and more comfortable.
